Psychiatric diseases in children and adolescents

Gabrielle Sky Cardwell, Robert L. Findling, Adelaide S. Robb

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Pharmacotherapy of psychiatric illnesses in children and adolescents has grown significantly over the last few decades. However, the body of research examining pharmacological treatments for psychiatric illnesses is much smaller in children and adolescents than it is in adults. As most treatments for psychiatric disorders are more effective if started early in the course of illness, treatment options for youth are especially important in order to ensure better treatment outcomes. This chapter discusses currently approved medications to treat psychiatric disorders in children and adolescents. Research on medications that may be effective treatments but are not yet FDA approved is also discussed. The medications are broken down into major categories used in youth with psychiatric disorders including antidepressants, mood stabilizers, ADHD medications, and antipsychotics.

Original languageEnglish (US)
Title of host publicationHandbook of Experimental Pharmacology
PublisherSpringer
Pages397-413
Number of pages17
DOIs
StatePublished - 2020

Publication series

NameHandbook of Experimental Pharmacology
Volume261
ISSN (Print)0171-2004
ISSN (Electronic)1865-0325

Keywords

  • Antidepressants
  • Antipsychotics
  • Child psychiatry
  • Mood stabilizers
  • Pediatric psychopharmacology
  • Stimulant medications

ASJC Scopus subject areas

  • Biochemistry
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Psychiatric diseases in children and adolescents'. Together they form a unique fingerprint.

Cite this